This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trager, G M
Right arrow Articles by Panwalker, A P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trager, G M
Right arrow Articles by Panwalker, A P

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1979 September; 16(3): 297-300

LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity.

G M Trager, G W White, V M Zimelis and A P Panwalker

ABSTRACT

The in vitro activity of LY-127935, a new beta-lactam antibiotic, was examined by using 370 clinical bacterial strains. In comparison with several other beta-lactam agents, LY-127935 was the most inhibitory against the Enterobacteriaceae. It was remarkably active against multi-drug-resistant strains of Enterobacter spp., Serratia spp., and Pseudomonas aeruginosa. LY-127935 had four- to eightfold greater activity than did cefoxitin against Bacteroides fragilis. Production of beta-lactamase by Enterobacteriaceae did not influence the minimal inhibitory concentration of LY-127935. However, the beta-lactamase-producing strains of B. fragilis and Haemophilus influenzae had generally higher minimal inhibitory concentrations. LY-127935 was the least active agent tested against gram-positive aerobic cocci. Variations in pH, salt content, protein content, or inocula size had little influence on susceptibility to LY-127935. Although combination studies with LY-127935 and gentamicin demonstrated synergy for P. aeruginosa, the rates of killing for the combination and for gentamicin alone were similar.


Antimicrob Agents Chemother. 1979 September; 16(3): 297-300




This article has been cited by other articles:

  • Fett, D. R., Silverman, C. A., Yoshizumi, M. O. (1984). Moxalactam Retinal Toxicity. Arch Ophthalmol 102: 435-438 [Abstract]  
  • Axelrod, J. L., Kochman, R. S. (1982). Moxalactam Concentration in Human Aqueous Humor After Intravenous Administration. Arch Ophthalmol 100: 1334-1336 [Abstract]  
  • RAHAL, J. J., SIMBERKOFF, M. S. (1982). Host Defense and Antimicrobial Therapy in Adult Gram-Negative Bacillary Meningitis. ANN INTERN MED 96: 468-474 [Abstract]  
  • Uwaydah, M. M., Jabbour, N., Fahd, S., Jaafar, M., Faris, B. M. (1982). Penetration of Intravenous Moxalactam Into Human Aqueous Humor. Arch Ophthalmol 100: 329-330 [Abstract]